During the past decade, Chang-Hua Christian Hospital conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 20 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 14 clinical trials were completed. i.e. 42.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chang-Hua Christian Hospital" #1 sponsor was "Boehringer Ingelheim" with 10 trials, followed by "Changhua Christian Hospital" with 10 trials sponsored, "Pfizer" with 8 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Gilead Sciences" with 4 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chang-Hua Christian Hospital" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Genovate Biotechnology Co., Ltd.," with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Chang-Hua Christian Hospital" are "Hemophilia A" (3 trials), "Non-Small Cell Lung Cancer" (3 trials), "Accidental Falls" (2 trials), "Atrial Fibrillation" (2 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Chang-Hua Christian Hospital" in a lesser frequency.

Most popular intervention types in "Chang-Hua Christian Hospital" are "Drug" (60 trials), "Other" (6 trials), "Device" (4 trials), "Biological" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Cisplatin" (4 trials), "Docetaxel" (3 trials), "Guselkumab" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chang-Hua Christian Hospital" are 65 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Chang-Hua Christian Hospital". undefined are not yet recruiting, 15 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Chang-Hua Christian Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Chang-Hua Christian Hospital, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".